2.00

0.99% -0.02

After Hours: 1.99 -0.01 -0.50%

Aytu Biopharma Inc (AYTU)

Overview News Price History Financials Why AYTU Down? Discussions Forecast Stock Split

Aytu Biopharma Inc stock is traded at $2.00, with a volume of 47,496. It is down -0.99% in the last 24 hours and down -12.66% over the past month. Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Previous Close:

$2.02

Open:

$2.02

24h Volume:

47,496

Relative Volume:

0.27

Market Cap:

$17.95M

Revenue:

$66.38M

Net Income/Loss:

$-14.18M

P/E Ratio:

-0.7124

EPS:

-2.8074

Net Cash Flow:

$-5.17M

1W Performance:

-2.91%

1M Performance:

-12.66%

6M Performance:

+0.00%

1Y Performance:

+25.38%

1-Day Range:

$2.00

$2.0999

1-Week Range:

$1.96

$2.30

52-Week Range:

$0.95

$2.82

Aytu Biopharma Inc Stock (AYTU) Company Profile

Name

Aytu Biopharma Inc

Sector

Healthcare (1130)

Industry

Drug Manufacturers - Specialty & Generic (85)

Phone

(720) 437-6580

Address

7900 E. UNION AVENUE, DENVER

Employee

Twitter

@aytubioscience

Next Earnings Date

2024-12-13

Latest SEC Filings

AYTU's Discussions on Twitter

Compare AYTU with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AYTU Aytu Biopharma Inc	2.00	20.58M	66.38M	-14.18M	-5.17M	-2.8074
ZTS Zoetis Inc	117.08	52.06B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	14.09	44.45B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.51	42.79B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	24.44	28.50B	16.70B	-157.13M	1.19B	-0.1446
UTHR United Therapeutics Corp	476.54	20.52B	3.08B	1.24B	1.07B	25.61

Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-01-25	Initiated	Lake Street	Buy
Jun-30-25	Initiated	Ascendiant Capital Markets	Buy
Mar-30-21	Initiated	Cantor Fitzgerald	Overweight
May-29-20	Initiated	H.C. Wainwright	Buy

Aytu Biopharma Inc Stock (AYTU) Latest News

Nov 19, 2025

What risks investors should watch in Aytu BioPharma Inc. stockQuarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com

Nov 19, 2025

Is Aytu BioPharma Inc. stock cheap at current valuation2025 Market Trends & Expert Curated Trade Ideas - newser.com

Nov 19, 2025

Pre Market Movers: NUTX, AYTU, NOTV Swing Big - RTTNews

Nov 19, 2025

What MACD signals say about Aytu BioPharma Inc.July 2025 Update & Low Drawdown Trading Techniques - newser.com

Nov 19, 2025

Why Aytu BioPharma Inc. (AY20) stock is trending on social mediaPortfolio Performance Report & Consistent Profit Focused Trading Strategies - newser.com

Nov 19, 2025

Why Aytu BioPharma Inc. stock remains resilientJuly 2025 Outlook & Short-Term Trading Alerts - newser.com

Nov 19, 2025

Regression analysis insights on Aytu BioPharma Inc. performance2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com

Nov 19, 2025

Nov 18, 2025

Aytu BioPharma : Corporate Presentation November 2025 View Presentation - MarketScreener

Nov 18, 2025

Will Aytu BioPharma Inc. (AY20) stock profit from fiscal stimulusQuarterly Investment Review & High Conviction Investment Ideas - newser.com

Nov 18, 2025

How Aytu BioPharma Inc. (AY20) stock moves in volatile trading sessionsDay Trade & Daily Technical Stock Forecast Reports - newser.com

Nov 18, 2025

Nov 17, 2025

Will Aytu BioPharma Inc. stock attract more institutional investorsWeekly Volume Report & Community Shared Stock Ideas - newser.com

Nov 17, 2025

Aytu BioPharma, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st

Nov 17, 2025

Aytu BioPharma Inc AY20 Stock Analysis and ForecastMACD Histogram Signals & Superior Trading Ideas - earlytimes.in

Nov 17, 2025

Nov 15, 2025

How to escape a deep drawdown in Aytu BioPharma Inc.Market Activity Report & High Accuracy Investment Signals - newser.com

Nov 15, 2025

Does Aytu BioPharma Inc. qualify in momentum factor screeningTrade Risk Summary & Consistent Return Strategy Ideas - newser.com

Nov 15, 2025

Is Aytu BioPharma Inc. stock ready for a breakoutTake Profit & Low Drawdown Investment Ideas - newser.com

Nov 15, 2025

Will Aytu BioPharma Inc. stock see insider buyingMarket Growth Review & Consistent Profit Trading Strategies - newser.com

Nov 15, 2025

Relative strength of Aytu BioPharma Inc. in sector analysisWeekly Profit Recap & Verified Momentum Stock Watchlist - newser.com

Nov 15, 2025

Understanding Aytu BioPharma Inc.’s price movementJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 15, 2025

Aytu BioPharma outlines $10M EXXUA launch investment and targets breakeven at $17.3M quarterly revenue as ADHD franchise holds strong - MSN

Nov 15, 2025

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2026 Earnings Call Transcript - Insider Monkey

Nov 15, 2025

Will Aytu BioPharma Inc. (AY20) stock keep high P E multiples2025 Technical Overview & Stock Portfolio Risk Management - newser.com

Nov 15, 2025

Nov 14, 2025

Earnings call transcript: Aytu BioPharma’s Q1 2025 shows stable stock By Investing.com - Investing.com Australia

Nov 14, 2025